The control of hepatic glycogen metabolism is vested solely in the enzymes glycogen synthetase and phosphorylase. Each enzyme exists in two main forms, which interconvert by means of a phosphorylation-dephosphorylation cycle. The rate of net glycogenolysis in liver is closely proportional to the assayable activity of phosphorylase a in liver, under various conditions, whereas the rate of net glycogen synthesis is proportional t o the assayable activity of synthetase a (Hers, 1976) . Hence these two forms, phosphorylase a (a phosphoprotein) and synthetase a (a dephosphorylated form), are the predominant active forms of these two catalysts in liver (Hers, 1976) .
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The glycogen debranching process does not seem to be rate-limiting in liver, in any state tested so far. During maximal anaerobic glycogenolysis, no change in average lengths of inner and outer chains is detectable (Birch et al., 1974) . Control of the branching enzyme in synthesis has not been systematically investigated.
There are complex inter-relationships between glycogen synthetase and phosphorylase.
Two major ones are the following: ( I ) since the active forms are respectively the dephospho and phospho forms, protein kinase activity will tend t o increase the quantity of oneactive protein and decrease the other; (2) since phosphorylaseacan inhibit synthetase b phosphatase, changes in amount of phosphorylase a (from whatever cause) will engender opposite changes in the proportion of synthetase in the a form (Hers, 1976) . However, there are also regulatory responses of phosphorylase and synthetase that are not inter-dependent, at least in the short term. Some hormonal responses will be brought out in the present paper.
Hormonal control of glycogenolysis
To establish that glycogenolysis may be directly induced in liver by a hormone, experiments with isolated liver preparations must be carried out. In recent years two excellent preparations have been developed for routine use, namely the perfused liver and suspensions of parenchymal cells.
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By using the perfused liver preparation (in confirmation of previous studies with liver slices), it may easily be shown that degradation of glycogen can be rapidly stimulated by direct hepatic action of a range of hormones. Well-established effects are those of glucagon and adrenaline (Sutherland & Robison, 1969; .
Other hormones that can directly induce immediate hepatic glycogenolysis include vassopressin, oxytocin, angiotensin I1 and parathyrin .
All hormones that stimulate hepatic glycogenolysis act by increasing the amount of phosphorylase a in the tissue. However, the mechanisms whereby these hormones exert their glycogenolytic effect fall into at least two groups.
Glucagon and 8-adrenergic agonists exert their glycogenolytic action via the sequence of events ('cascade') featuring cyclic AMP Robison et al., 1968) .
This mechanism remains one of the few cases where the entire sequence of events has been pieced together, from the hormone interaction with the adenylate cyclase receptor subunit, via cyclic AMP, to the ultimate protein phosphorylation, i.e. phosphorylase kinase activation. A second group of hormones do not act via cyclic AMP when stimulating glycogenolysis. The first clue that this might be true emerged from a study of adrenergicreceptor mechanisms, which suggested that the a-adrenergic mechanism might not involve cyclic AMP (Sherline et d., 1972) . Also, vasopressin does not increase the cyclic AMP content in liver (Kirk & Hems, 1974) . Neither vasopressin nor angiotensin stimulates the assayable phosphorylase kinase activity in liver (Keppens et al., 1977) .
Cyclic GMP is also not implicated in the glycogenolytic effect of adrenaline, vasopressin, oxytocin or angiotensin 11, as these hormones do not increase the content of this nucleotide in the perfused liver (K. Siddle, C. Davies and D. A. Hems, unpublished work).
If purine nucleoside cyclic monophosphates are not implicated in the mechanism of action of this group of hormones, then what is the mechanism? So far, there are two observations which shed light on this question. The increases in phosphorylase a ( Table  1 Table 1 . Concentration-dependence androle of Ca2+ in hormonalstimulation of the content ofphosphorylase a in hepatocytes Hepatocytes (prepared as described by Whitton et a/., 1977) were incubated in standard medium or Caz+-free medium containing ~~M -E G T A ; both media contained 20mM-glucose. After 30min, hormones at various concentrations were added. Phosphorylase a (whose activity is given as pmol of glucose transferred/min per g of dry cells) was assayed in normal and Ca2+-free medium, 2min after addition of hormones. Results are m e a n s k~.~.~. for three to five cell preparations. The results were obtained in experiments carried out by Dr. P. Whitton, and are given here with her permission. -Jeannet et al., 1977) . Phosphatidylinositol also appears to be implicated in the response of liver to vasopressin. Thus vasopressin can stimulate the incorporation of Pi into phosphatidylinositol in hepatocytes (Kirk et a/., 1977) . This effect is specific, as it was not manifested by other phospholipids. Glucagon which also stimulates glycogenolysis, does not affect phosphatidylinositol turnover. The effect of vasopressin on phosphatidylinositol synthesis is maximal 2min after addition of hormone, which suggests that this response could be implicated in the response of phosphorylase a to vasopressin, e.g. via regulation of membrane-transport processes. In summary, there are at least two groups of hormones that can rapidly stimulate glycogenolysis in liver, via an increase in the amount of phosphophosphorylase (i.e. a form) in liver. Phosphorylase kinase is the control site that links these mechanisms. One group of hormones act via cyclic A M P and phosphorylation of phosphorylase kinase, and the other via Ca2+ and perhaps pfiosphatidylinositol. The latter group, which d o not bring about phosphorylation of phosphorylase kinase (Keppens et al., 
Hormonal control of glycogen synthesis
So far, there is no reproducible documented case of direct hormonal stimulation of net glycogen synthesis or synthetase activity in liver. Thus insulin does not directly promote net glycogen synthesis in perfused liver (Whitton & Hems, 1975; Sparks er al., 1976) , or in hepatocyte suspensions (Seglen, 1973) . Cortisol also does not promote synthesis by direct short-term hepatic action (Whitton & Hems, 1976) .
Hepatic glycogen synthetase is, however, activated in intact animals by insulin or glucocorticoids (see references in Whitton & Hems, 1975 . How then does this occur? One mechanism is that insulin can counteract the activation of phosphorylase a in liver by hormones with a glycogenolytic action. This is true both of hormones such as glucagon (Exton & Park, 1972; , which act via cyclic AMP, and of phenylephrine (an a-agonist), which does not (Van de Werve et al., 1977) . In the intact animal, where the catabolic-acting hormones are naturally present, counteraction by insulin will therefore occur and would lead to an eventual increase in synthetase a.
Given that insulin is released into the hepatic portal vein, and that its first target is the liver, it nevertheless remains possible that insulin, acting directly on the liver, can promote glycogen synthesis. Thus a simple explanation of the failure (so far) to elucidate a consistent effect of the hormone is that cofactor(s) in blood (e.g. substrates or hormones) act in concert with insulin. If this is so, they still have to be identified.
In liver from diabetic rats, the intrinsic hepatic capacity for glycogen synthesis is impaired (Whitton & Hems, 1975;  Table 2 ). The defect can be corrected by insulin in uiuo in 1-2h. There is evidence that the insulin-dependent mechanism for promoting hepatic glycogen synthesis involves the activation of glycogen synthetase (i.e. conversion of the b into the a form, which is a dephosphorylation) in response to glucose. It is this mechanism which is impaired in diabetes. But activation of synthetase is not in itself sufficient for net glycogen synthesis in liver from diabetic rats, as shown by the fact that fructose can produce high activities ( Table 2 ) of synthetase a in such livers, but without associated normal rates of synthesis (Whitton & Hems, 1975) . Therefore the defective synthetase-activation response in diabetic liver cannot involve the mechanism operated via the inhibition of synthetase phosphatase by phosphorylase a (Hers, 1976) , as this Table 2 . GIycogen synthetase activity in perfused liver of starved rats
Livers of 48 h-starved rats were perfused (Hems et al., 1972) with bicarbonate-buffered saline containing serum albumin, erythrocytes, glucose ( 3 0 m~) and gluconeogenic precursors [either fructose or a mixture of lactate, pyruvate and glycerol (C, mixture)] as indicated. Rats were made diabetic with streptozotocin, or bilaterally adrenalectomized, about 1 week before they were killed. Net glycogen synthesis and the change in activity of synthetase a (expressed as a percentage of total activity in the a form) were followed from analysis of two liver biopsies (removed after 20 and 50min of perfusion). The results are summarized from Whitton & Hems (1975 , 1976 and reproduced with the permission of the publishers. mechanism would predict that high synthetase a activity would itself be sufficient for synthesis. Therefore insulin appears to promote a glucose-dependent process for activating glycogen synthetase, by a mechanism that does not involve direct rapid action of insulin (as sole hormone) on liver. The ultimate effect of this process (in response to glucose) in normal cells is to increase the synthetase a content in liver; its intermediary steps are obscure.
In the isolated liver of starved animals, glucose serves to promote glycogen synthesis, but does not provide a net carbon supply (Hems et al., 1972) . As one approach to the problem of control of hepatic glycogen synthesis by hexoses, we have investigated the promotion of net glycogen synthesis by sugars in the perfused liver . D-Galactose can promote synthesis in the same way as glucose, i.e. not just by serving as acarbon source for glycogen, but as a positive modifier of synthesis. Galactose can activate synthetase, acting in concert with glucose (Sparks et a[., 1976) ; yet galactose, unlike glucose, does not activate phosphorylase a phosphatase . Other hexoses do not substitute for glucose or galactose in promoting net synthesis, indicating that the hydroxyl groups on carbon positions other than C-4 in glucose must be of correct configuration to activate synthesis.
One theory that explains these observations is that there is an insulin-dependent hexose receptor in the liver cell which operates to promote glycogen synthesis, and which is not phosphorylase a phosphatase.
It is well known that adrenal glucocorticoids can promote glycogen deposition in the intact animal (as can insulin). However, on the evidence so far, adrenal glucocorticoids do not exert any direct hepatic short-term stimulatory effect on glycogen synthesis ( Table 2 ). The adrenal-cortical status of the animal can indirectly affect glycogen metabolism, via plasma insulin concentration, which alters in parallel with the glucocorticoid concentration (see the Discussion in Whitton & Hems, 1976) .
The above considerations show that current knowledge about hormonal promotion of glycogen synthesis is derisory. Indeed there may be n o hormones that act rapidly and directly (as sole hormone) on liver to promote synthesis. Of course, the hormones described previously which promote glycogenolysis would also inhibit synthesis if tested under appropriate conditions.
